MMP9 and neoplasm: Zoledronate, a third-generation bisphosphonate, is cytotoxic to TAMs that express matrix metalloproteinase-9 (MMP9) and improves macrophage anti-tumor activity by polarizing monocytes toward pro-inflammatory phenotype [76, 82].